Temperature Controlled Logistics And Security

September 20-22, 2022 | USA

Temperature Controlled
We are the world’s most innovative and educational event covering all you need to know about optimizing your end-to-end supply chain from a patient-centric, regulatory-compliant and cost effective perspective.
Register Now

Spotlight

Dr. Chris Leptak of the FDA’s Center for Drug Evaluation and Research discusses the three primary sources for biomarker evidence use by FDA to inform regulatory decisions – scientific community consensus, drug-specific development and approval process, and CDER’s Biomarker Qualification Program. No matter which pathway the drug developer selects, consulting with the FDA is a critical step to achieve success.


OTHER UPCOMING CONFERENCES

Pharmaceutics & Novel Drug Delivery Systems

November 14-15, 2022 | UAE

The Coalesce Research Group is pleased to invites participants from all over the world to attend “2ndInternational Conference on Pharmaceutics & Novel Drug Delivery Systems” during November 14-15, 2022 in Dubai, UAE
Register Now

80TH FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

September 18-22, 2022 | Spain

At this critical time, when the challenges presented by the COVID-19 pandemic are still current and on the minds of healthcare professionals, we must take the opportunity to create more comprehensive plans to better manage health crises that may be on the horizon.
Register Now

4th International Conference on Alternative Medicine

July 15-16, 2022 | USA

Alternative & Integrative Medicine2022 is honored to extend an invitation to all notable individuals from around the world to the "4th International Conference on Alternative Medicine," which will be held as a Webinar on July 15-16, 2022.
Register Now

iPharma Expo 2022

October 20-21, 2022 | USA

After a series of many successful pharma and medical conferences and expos for the past many years, we are happy to announce the International Pharmaceutical Business Expo, iPharma Expo 2022 at Boston, USA during October 20- 21, 2022.
Register Now

Spotlight

Dr. Chris Leptak of the FDA’s Center for Drug Evaluation and Research discusses the three primary sources for biomarker evidence use by FDA to inform regulatory decisions – scientific community consensus, drug-specific development and approval process, and CDER’s Biomarker Qualification Program. No matter which pathway the drug developer selects, consulting with the FDA is a critical step to achieve success.

resources